Article
Membranous Nephropathy: Muti-omics Mendelian randomization and colocalization analysis
2023-11-22
Abstract excerpt
<h4>Background</h4> The currently available medications for treating membranous nephropathy (MN) still have unsatisfactory efficacy in inhibiting disease recurrence, slowing down its progression, and even halting the development of end-stage renal disease. There is still a need to develop novel drugs targeting MN. <h4>Methods</h4> We utilized summary statistics of MN from the Kiryluk Lab and obtained plasma protei...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c76f7246-166d-59b1-8a0a-1416f6fc75f3
- DOI
- 10.1101/2023.11.21.23298831
